1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiopharmaceutical Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Actinium-225
1.2.3 Lutetium-177
1.2.4 Radium-223
1.2.5 Holmium-166
1.2.6 Other
1.3 Market by Application
1.3.1 Global Radiopharmaceutical Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radiopharmaceutical Therapy Market Perspective (2018-2029)
2.2 Radiopharmaceutical Therapy Growth Trends by Region
2.2.1 Global Radiopharmaceutical Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Radiopharmaceutical Therapy Historic Market Size by Region (2018-2023)
2.2.3 Radiopharmaceutical Therapy Forecasted Market Size by Region (2024-2029)
2.3 Radiopharmaceutical Therapy Market Dynamics
2.3.1 Radiopharmaceutical Therapy Industry Trends
2.3.2 Radiopharmaceutical Therapy Market Drivers
2.3.3 Radiopharmaceutical Therapy Market Challenges
2.3.4 Radiopharmaceutical Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiopharmaceutical Therapy Players by Revenue
3.1.1 Global Top Radiopharmaceutical Therapy Players by Revenue (2018-2023)
3.1.2 Global Radiopharmaceutical Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Radiopharmaceutical Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Radiopharmaceutical Therapy Revenue
3.4 Global Radiopharmaceutical Therapy Market Concentration Ratio
3.4.1 Global Radiopharmaceutical Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiopharmaceutical Therapy Revenue in 2022
3.5 Radiopharmaceutical Therapy Key Players Head office and Area Served
3.6 Key Players Radiopharmaceutical Therapy Product Solution and Service
3.7 Date of Enter into Radiopharmaceutical Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiopharmaceutical Therapy Breakdown Data by Type
4.1 Global Radiopharmaceutical Therapy Historic Market Size by Type (2018-2023)
4.2 Global Radiopharmaceutical Therapy Forecasted Market Size by Type (2024-2029)
5 Radiopharmaceutical Therapy Breakdown Data by Application
5.1 Global Radiopharmaceutical Therapy Historic Market Size by Application (2018-2023)
5.2 Global Radiopharmaceutical Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Radiopharmaceutical Therapy Market Size (2018-2029)
6.2 North America Radiopharmaceutical Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Radiopharmaceutical Therapy Market Size by Country (2018-2023)
6.4 North America Radiopharmaceutical Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radiopharmaceutical Therapy Market Size (2018-2029)
7.2 Europe Radiopharmaceutical Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Radiopharmaceutical Therapy Market Size by Country (2018-2023)
7.4 Europe Radiopharmaceutical Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radiopharmaceutical Therapy Market Size (2018-2029)
8.2 Asia-Pacific Radiopharmaceutical Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Radiopharmaceutical Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Radiopharmaceutical Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radiopharmaceutical Therapy Market Size (2018-2029)
9.2 Latin America Radiopharmaceutical Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Radiopharmaceutical Therapy Market Size by Country (2018-2023)
9.4 Latin America Radiopharmaceutical Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiopharmaceutical Therapy Market Size (2018-2029)
10.2 Middle East & Africa Radiopharmaceutical Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Radiopharmaceutical Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Radiopharmaceutical Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bracco Imaging
11.1.1 Bracco Imaging Company Detail
11.1.2 Bracco Imaging Business Overview
11.1.3 Bracco Imaging Radiopharmaceutical Therapy Introduction
11.1.4 Bracco Imaging Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.1.5 Bracco Imaging Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Radiopharmaceutical Therapy Introduction
11.2.4 Bayer Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.2.5 Bayer Recent Development
11.3 Mallinckrodt
11.3.1 Mallinckrodt Company Detail
11.3.2 Mallinckrodt Business Overview
11.3.3 Mallinckrodt Radiopharmaceutical Therapy Introduction
11.3.4 Mallinckrodt Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.3.5 Mallinckrodt Recent Development
11.4 Nordion
11.4.1 Nordion Company Detail
11.4.2 Nordion Business Overview
11.4.3 Nordion Radiopharmaceutical Therapy Introduction
11.4.4 Nordion Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.4.5 Nordion Recent Development
11.5 Triad Isotopes
11.5.1 Triad Isotopes Company Detail
11.5.2 Triad Isotopes Business Overview
11.5.3 Triad Isotopes Radiopharmaceutical Therapy Introduction
11.5.4 Triad Isotopes Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.5.5 Triad Isotopes Recent Development
11.6 Lantheus
11.6.1 Lantheus Company Detail
11.6.2 Lantheus Business Overview
11.6.3 Lantheus Radiopharmaceutical Therapy Introduction
11.6.4 Lantheus Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.6.5 Lantheus Recent Development
11.7 IBA Group
11.7.1 IBA Group Company Detail
11.7.2 IBA Group Business Overview
11.7.3 IBA Group Radiopharmaceutical Therapy Introduction
11.7.4 IBA Group Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.7.5 IBA Group Recent Development
11.8 GE Healthcare
11.8.1 GE Healthcare Company Detail
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Radiopharmaceutical Therapy Introduction
11.8.4 GE Healthcare Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.8.5 GE Healthcare Recent Development
11.9 China Isotope & Radiation
11.9.1 China Isotope & Radiation Company Detail
11.9.2 China Isotope & Radiation Business Overview
11.9.3 China Isotope & Radiation Radiopharmaceutical Therapy Introduction
11.9.4 China Isotope & Radiation Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.9.5 China Isotope & Radiation Recent Development
11.10 Jubilant Pharma
11.10.1 Jubilant Pharma Company Detail
11.10.2 Jubilant Pharma Business Overview
11.10.3 Jubilant Pharma Radiopharmaceutical Therapy Introduction
11.10.4 Jubilant Pharma Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.10.5 Jubilant Pharma Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Detail
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Radiopharmaceutical Therapy Introduction
11.11.4 Eli Lilly Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.11.5 Eli Lilly Recent Development
11.12 Advanced Accelerator Applications
11.12.1 Advanced Accelerator Applications Company Detail
11.12.2 Advanced Accelerator Applications Business Overview
11.12.3 Advanced Accelerator Applications Radiopharmaceutical Therapy Introduction
11.12.4 Advanced Accelerator Applications Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.12.5 Advanced Accelerator Applications Recent Development
11.13 SIEMENS
11.13.1 SIEMENS Company Detail
11.13.2 SIEMENS Business Overview
11.13.3 SIEMENS Radiopharmaceutical Therapy Introduction
11.13.4 SIEMENS Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.13.5 SIEMENS Recent Development
11.14 Dongcheng
11.14.1 Dongcheng Company Detail
11.14.2 Dongcheng Business Overview
11.14.3 Dongcheng Radiopharmaceutical Therapy Introduction
11.14.4 Dongcheng Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.14.5 Dongcheng Recent Development
11.15 Navidea
11.15.1 Navidea Company Detail
11.15.2 Navidea Business Overview
11.15.3 Navidea Radiopharmaceutical Therapy Introduction
11.15.4 Navidea Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.15.5 Navidea Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Radiopharmaceutical Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Actinium-225
Table 3. Key Players of Lutetium-177
Table 4. Key Players of Radium-223
Table 5. Key Players of Holmium-166
Table 6. Key Players of Other
Table 7. Global Radiopharmaceutical Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Radiopharmaceutical Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Radiopharmaceutical Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Radiopharmaceutical Therapy Market Share by Region (2018-2023)
Table 11. Global Radiopharmaceutical Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Radiopharmaceutical Therapy Market Share by Region (2024-2029)
Table 13. Radiopharmaceutical Therapy Market Trends
Table 14. Radiopharmaceutical Therapy Market Drivers
Table 15. Radiopharmaceutical Therapy Market Challenges
Table 16. Radiopharmaceutical Therapy Market Restraints
Table 17. Global Radiopharmaceutical Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Radiopharmaceutical Therapy Market Share by Players (2018-2023)
Table 19. Global Top Radiopharmaceutical Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Therapy as of 2022)
Table 20. Ranking of Global Top Radiopharmaceutical Therapy Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Radiopharmaceutical Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Radiopharmaceutical Therapy Product Solution and Service
Table 24. Date of Enter into Radiopharmaceutical Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Radiopharmaceutical Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Radiopharmaceutical Therapy Revenue Market Share by Type (2018-2023)
Table 28. Global Radiopharmaceutical Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Radiopharmaceutical Therapy Revenue Market Share by Type (2024-2029)
Table 30. Global Radiopharmaceutical Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Radiopharmaceutical Therapy Revenue Market Share by Application (2018-2023)
Table 32. Global Radiopharmaceutical Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Radiopharmaceutical Therapy Revenue Market Share by Application (2024-2029)
Table 34. North America Radiopharmaceutical Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Radiopharmaceutical Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Radiopharmaceutical Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Radiopharmaceutical Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Radiopharmaceutical Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Radiopharmaceutical Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Radiopharmaceutical Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Radiopharmaceutical Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Radiopharmaceutical Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Radiopharmaceutical Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Radiopharmaceutical Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Radiopharmaceutical Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Radiopharmaceutical Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Radiopharmaceutical Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Radiopharmaceutical Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 49. Bracco Imaging Company Detail
Table 50. Bracco Imaging Business Overview
Table 51. Bracco Imaging Radiopharmaceutical Therapy Product
Table 52. Bracco Imaging Revenue in Radiopharmaceutical Therapy Business (2018-2023) & (US$ Million)
Table 53. Bracco Imaging Recent Development
Table 54. Bayer Company Detail
Table 55. Bayer Business Overview
Table 56. Bayer Radiopharmaceutical Therapy Product
Table 57. Bayer Revenue in Radiopharmaceutical Therapy Business (2018-2023) & (US$ Million)
Table 58. Bayer Recent Development
Table 59. Mallinckrodt Company Detail
Table 60. Mallinckrodt Business Overview
Table 61. Mallinckrodt Radiopharmaceutical Therapy Product
Table 62. Mallinckrodt Revenue in Radiopharmaceutical Therapy Business (2018-2023) & (US$ Million)
Table 63. Mallinckrodt Recent Development
Table 64. Nordion Company Detail
Table 65. Nordion Business Overview
Table 66. Nordion Radiopharmaceutical Therapy Product
Table 67. Nordion Revenue in Radiopharmaceutical Therapy Business (2018-2023) & (US$ Million)
Table 68. Nordion Recent Development
Table 69. Triad Isotopes Company Detail
Table 70. Triad Isotopes Business Overview
Table 71. Triad Isotopes Radiopharmaceutical Therapy Product
Table 72. Triad Isotopes Revenue in Radiopharmaceutical Therapy Business (2018-2023) & (US$ Million)
Table 73. Triad Isotopes Recent Development
Table 74. Lantheus Company Detail
Table 75. Lantheus Business Overview
Table 76. Lantheus Radiopharmaceutical Therapy Product
Table 77. Lantheus Revenue in Radiopharmaceutical Therapy Business (2018-2023) & (US$ Million)
Table 78. Lantheus Recent Development
Table 79. IBA Group Company Detail
Table 80. IBA Group Business Overview
Table 81. IBA Group Radiopharmaceutical Therapy Product
Table 82. IBA Group Revenue in Radiopharmaceutical Therapy Business (2018-2023) & (US$ Million)
Table 83. IBA Group Recent Development
Table 84. GE Healthcare Company Detail
Table 85. GE Healthcare Business Overview
Table 86. GE Healthcare Radiopharmaceutical Therapy Product
Table 87. GE Healthcare Revenue in Radiopharmaceutical Therapy Business (2018-2023) & (US$ Million)
Table 88. GE Healthcare Recent Development
Table 89. China Isotope & Radiation Company Detail
Table 90. China Isotope & Radiation Business Overview
Table 91. China Isotope & Radiation Radiopharmaceutical Therapy Product
Table 92. China Isotope & Radiation Revenue in Radiopharmaceutical Therapy Business (2018-2023) & (US$ Million)
Table 93. China Isotope & Radiation Recent Development
Table 94. Jubilant Pharma Company Detail
Table 95. Jubilant Pharma Business Overview
Table 96. Jubilant Pharma Radiopharmaceutical Therapy Product
Table 97. Jubilant Pharma Revenue in Radiopharmaceutical Therapy Business (2018-2023) & (US$ Million)
Table 98. Jubilant Pharma Recent Development
Table 99. Eli Lilly Company Detail
Table 100. Eli Lilly Business Overview
Table 101. Eli Lilly Radiopharmaceutical Therapy Product
Table 102. Eli Lilly Revenue in Radiopharmaceutical Therapy Business (2018-2023) & (US$ Million)
Table 103. Eli Lilly Recent Development
Table 104. Advanced Accelerator Applications Company Detail
Table 105. Advanced Accelerator Applications Business Overview
Table 106. Advanced Accelerator Applications Radiopharmaceutical Therapy Product
Table 107. Advanced Accelerator Applications Revenue in Radiopharmaceutical Therapy Business (2018-2023) & (US$ Million)
Table 108. Advanced Accelerator Applications Recent Development
Table 109. SIEMENS Company Detail
Table 110. SIEMENS Business Overview
Table 111. SIEMENS Radiopharmaceutical Therapy Product
Table 112. SIEMENS Revenue in Radiopharmaceutical Therapy Business (2018-2023) & (US$ Million)
Table 113. SIEMENS Recent Development
Table 114. Dongcheng Company Detail
Table 115. Dongcheng Business Overview
Table 116. Dongcheng Radiopharmaceutical Therapy Product
Table 117. Dongcheng Revenue in Radiopharmaceutical Therapy Business (2018-2023) & (US$ Million)
Table 118. Dongcheng Recent Development
Table 119. Navidea Company Detail
Table 120. Navidea Business Overview
Table 121. Navidea Radiopharmaceutical Therapy Product
Table 122. Navidea Revenue in Radiopharmaceutical Therapy Business (2018-2023) & (US$ Million)
Table 123. Navidea Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Radiopharmaceutical Therapy Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Radiopharmaceutical Therapy Market Share by Type: 2022 VS 2029
Figure 3. Actinium-225 Features
Figure 4. Lutetium-177 Features
Figure 5. Radium-223 Features
Figure 6. Holmium-166 Features
Figure 7. Other Features
Figure 8. Global Radiopharmaceutical Therapy Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Radiopharmaceutical Therapy Market Share by Application: 2022 VS 2029
Figure 10. Oncology Case Studies
Figure 11. Cardiology Case Studies
Figure 12. Other Case Studies
Figure 13. Radiopharmaceutical Therapy Report Years Considered
Figure 14. Global Radiopharmaceutical Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Radiopharmaceutical Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Radiopharmaceutical Therapy Market Share by Region: 2022 VS 2029
Figure 17. Global Radiopharmaceutical Therapy Market Share by Players in 2022
Figure 18. Global Top Radiopharmaceutical Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Therapy as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Radiopharmaceutical Therapy Revenue in 2022
Figure 20. North America Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Radiopharmaceutical Therapy Market Share by Country (2018-2029)
Figure 22. United States Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Radiopharmaceutical Therapy Market Share by Country (2018-2029)
Figure 26. Germany Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Radiopharmaceutical Therapy Market Share by Region (2018-2029)
Figure 34. China Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Radiopharmaceutical Therapy Market Share by Country (2018-2029)
Figure 42. Mexico Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Radiopharmaceutical Therapy Market Share by Country (2018-2029)
Figure 46. Turkey Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Radiopharmaceutical Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Bracco Imaging Revenue Growth Rate in Radiopharmaceutical Therapy Business (2018-2023)
Figure 49. Bayer Revenue Growth Rate in Radiopharmaceutical Therapy Business (2018-2023)
Figure 50. Mallinckrodt Revenue Growth Rate in Radiopharmaceutical Therapy Business (2018-2023)
Figure 51. Nordion Revenue Growth Rate in Radiopharmaceutical Therapy Business (2018-2023)
Figure 52. Triad Isotopes Revenue Growth Rate in Radiopharmaceutical Therapy Business (2018-2023)
Figure 53. Lantheus Revenue Growth Rate in Radiopharmaceutical Therapy Business (2018-2023)
Figure 54. IBA Group Revenue Growth Rate in Radiopharmaceutical Therapy Business (2018-2023)
Figure 55. GE Healthcare Revenue Growth Rate in Radiopharmaceutical Therapy Business (2018-2023)
Figure 56. China Isotope & Radiation Revenue Growth Rate in Radiopharmaceutical Therapy Business (2018-2023)
Figure 57. Jubilant Pharma Revenue Growth Rate in Radiopharmaceutical Therapy Business (2018-2023)
Figure 58. Eli Lilly Revenue Growth Rate in Radiopharmaceutical Therapy Business (2018-2023)
Figure 59. Advanced Accelerator Applications Revenue Growth Rate in Radiopharmaceutical Therapy Business (2018-2023)
Figure 60. SIEMENS Revenue Growth Rate in Radiopharmaceutical Therapy Business (2018-2023)
Figure 61. Dongcheng Revenue Growth Rate in Radiopharmaceutical Therapy Business (2018-2023)
Figure 62. Navidea Revenue Growth Rate in Radiopharmaceutical Therapy Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
